Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|40|4447-4469

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.40, 2018-01, pp. : 4447-4469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Anti-Cancer Therapies for Renal Cancer

By Amato Robert J.   Jac Jaroslaw  

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2161-2171

Adis International

Access to resources Recommend Favorite

Calpains as potential anti-cancer targets

By Leloup Ludovic   Wells Alan  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 309-323

Informa Healthcare

Access to resources Recommend Favorite

Somatostatin Receptor-Targeted Anti-Cancer Therapy

By  

Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite

Garcinia mangostana: a source of potential anti-cancer lead compounds against CEM-SS cell line

By Ee Gwendoline Cheng Lian   Daud Shaari   Izzaddin Sheikh Ahmad   Rahmani Mawardi  

Journal of Asian Natural Products Research, Vol. 10, Iss. 5, 2008-05 ,pp. : 481-485

Taylor & Francis Ltd

Access to resources Recommend Favorite

Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy

By Krasnov George S   Dmitriev Alexey A   Lakunina Valentina A   Kirpiy Alexander A   Kudryavtseva Anna V  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1221-1233

Informa Healthcare

Access to resources Recommend Favorite